Trifocal Intraocular Lens | Professor Gus Gazzard, Consultant Ophthalmologist

Professor Gazzard offers complex premium lenses such as Alcon Laboratories, Inc. AcrySof® IQ PanOptix® Trifocal Intraocular Lens and AcrySof® IQ PanOptix® Toric Trifocal Intraocular Lens

These are artificial lenses (Intraocular lens or IOL) implanted in the eye that is used to improve vision after cataract removal in people who also have blurred vision due to an irregularly shaped cornea (corneal astigmatism).

Trifocal lens image The AcrySof® IQ PanOptix® Trifocal Intraocular Lens and AcrySof® IQ PanOptix® Toric Trifocal Intraocular Lens works by bending light rays to allow them to focus on the retina (the back surface of the eye) to provide for improved distance (for example, driving, playing golf), intermediate, and near vision. It is implanted in patients 22 years of age or older, with less than 1 diopter of pre-existing corneal astigmatism, and have had cataract surgery.

This lens reduces the effects of presbyopia (inability to focus on close images, such as reading) by providing improved intermediate and near clear vision, while maintaining comparable distance clear vision with a reduced need for eyeglasses, compared to a monofocal (one focusing distance) IOL.

In a clinical study of 243 patients implanted with either the PanOptix lens or a control lens, a total of 129 patients (256 eyes) were implanted with the PanOptix lens (127 in both eyes), and 2 patients in one eye. A total of 114 patients (225 eyes) were implanted with the control lens (111 in both eyes, 3 in one eye).

After six months of implantation, the average best corrected distance with clear vision in one eye tested was approximately 20/20 for each study group. For intermediate distance, clear vision in one eye with the PanOptix lens was approximately 20/25 compared to 20/40 for the control group. The clear vision for near distance correction with the PanOptix lens was approximately 20/25, compared to 20/63 for the control group. Overall, there were no safety concerns during the study.

If you’d like to know more about whether this innovative treatment is an option for you, or think that you may benefit from a consultation, please get in touch here.